XML 30 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Instruments
12 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 4. Derivative Instruments

The notional amount of the Company's derivative instruments is summarized as follows (in millions):
 As of December 31,
 20232022
Designated derivatives:
Cash flow hedges:
Foreign currency contracts$801.0 $775.9 
Interest rate lock contracts— 650.0 
Fair value hedges:
Interest rate swap contracts600.0 600.0 
Total designated derivatives
$1,401.0 $2,025.9 
Non-designated derivatives200.7 163.5 
Total
$1,601.7 $2,189.4 

The fair value of derivative instruments on the Consolidated Balance Sheets was as follows:
 As of December 31,
 Balance Sheet Location20232022
Derivative assets:
Derivatives designated as hedging instruments:
Foreign currency contracts as cash flow hedgesOther current assets$4.4 $0.7 
Foreign currency contracts as cash flow hedgesOther long-term assets2.7 0.5 
Interest rate lock contractsOther long-term assets— 125.4 
Total derivatives designated as hedging instruments$7.1 $126.6 
Derivatives not designated as hedging instrumentsOther current assets0.1 0.1 
Total derivative assets$7.2 $126.7 
Derivative liabilities:
Derivatives designated as hedging instruments:
Foreign currency contractsOther accrued liabilities$6.0 $32.3 
Foreign currency contractsOther long-term liabilities1.0 5.1 
Interest rate swap contractsOther long-term liabilities73.6 87.4 
Total derivatives designated as hedging instruments$80.6 $124.8 
Derivatives not designated as hedging instrumentsOther accrued liabilities0.2 0.2 
Total derivative liabilities$80.8 $125.0 

Offsetting of Derivative Instruments

The Company presents its derivative instruments at gross fair values in the Consolidated Balance Sheets. As of December 31, 2023 and December 31, 2022, the potential effects of set-off associated with the derivative contracts would be a reduction to both derivative assets and derivative liabilities by $7.2 million and $73.8 million, respectively.

Designated Derivatives

The Company uses foreign currency forward contracts or options contracts to hedge the Company's planned cost of revenues and operating expenses denominated in foreign currencies. These derivatives are designated as cash flow hedges and typically have maturities of thirty-six months or less.
The Company enters into interest rate swap contracts, designated as fair value hedges, to convert the fixed interest rates of certain Senior Notes ("Notes") to floating interest rates. In April 2021, the Company entered into these contracts for an aggregate notional amount of $300.0 million for its fixed-rate Notes maturing in December 2030 in addition to the contracts entered in 2019 for an aggregate notional amount of $300.0 million for its fixed-rate Notes maturing in March 2041. The interest rate swap contracts will expire within seven years.

In 2020, the Company entered into interest rate lock contracts with large financial institutions, which fix the benchmark interest rates of future debt issuances for an aggregate notional amount of $650.0 million. These contracts were designated as cash flow hedges for a forecasted debt issuance which was expected to occur by the end of 2025. During the year ended December 31, 2023, the Company terminated the interest rate lock contracts, resulting in a deferred gain of $133.9 million recognized in accumulated other comprehensive income, which will be deferred and amortized to interest expense over the term of the anticipated debt unless it becomes probable that the debt will not be issued with the terms anticipated at the hedge's inception. The Company classifies the cash flow in the same section as the underlying item resulting in the proceeds from sale being presented as operating activities.

Effect of Derivative Instruments on the Consolidated Statements of Operations

For cash flow hedges, the Company recognized an unrealized gain of $15.1 million, unrealized gain of $33.1 million and unrealized loss of $9.1 million in accumulated other comprehensive loss for the effective portion of its derivative instruments during the years ended December 31, 2023, 2022, and 2021, respectively.

For foreign currency contracts, the Company reclassified a loss of $29.8 million, a loss of $25.8 million and a gain of $28.9 million out of accumulated other comprehensive loss to cost of revenues and operating expenses in the Consolidated Statements of Operations during the years ended December 31, 2023, 2022, and 2021, respectively. As of December 31, 2023, an estimated $1.6 million of unrealized net loss within accumulated other comprehensive income is expected to be reclassified into earnings within the next twelve months.

Non-Designated Derivatives

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. These foreign exchange forward contracts typically have maturities of approximately one to four months. The outstanding non-designated derivative instruments are carried at fair value. Changes in the fair value of these derivatives, which were recorded in Other expense, net within the Consolidated Statements of Operations, were not material during the years ended December 31, 2023, 2022, and 2021, respectively.

See Note 1, Description of Business, Basis of Presentation and Significant Accounting Policies, for the Company’s policy regarding the offsetting of derivative assets and derivative liabilities.